POLYSPORIN PLUS PAIN RELIEF EAR DROPS 10000 UNIT
POLYMYXIN B (POLYMYXIN B SULFATE) : 10000 UNIT LIDOCAINE HYDROCHLORIDE : 50 MG · DIN 02239155 · JOHNSON & JOHNSON INC
Health Canada status: MARKETED
What is POLYSPORIN PLUS PAIN RELIEF EAR DROPS?
POLYSPORIN PLUS PAIN RELIEF EAR DROPS 10000 UNIT contains POLYMYXIN B (POLYMYXIN B SULFATE) : 10000 UNIT LIDOCAINE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02239155, held by JOHNSON & JOHNSON INC, supplied as DROPS for OTIC administration. Health Canada currently lists it as marketed, status dated 27-Apr-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02239155 |
|---|---|
| Brand name | POLYSPORIN PLUS PAIN RELIEF EAR DROPS |
| Generic / active ingredient | POLYMYXIN B (POLYMYXIN B SULFATE) : 10000 UNIT LIDOCAINE HYDROCHLORIDE : 50 MG |
| Manufacturer | JOHNSON & JOHNSON INC |
| Strength | 10000 UNIT |
| Dosage form | DROPS |
| Route of administration | OTIC |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S02AA30 ANTIINFECTIVES, COMBINATIONS |
| AHFS class | 52:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Apr-2026 |
| Original market date | 1999-12-29 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S02AA30 ANTIINFECTIVES, COMBINATIONS. 1 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANTIBIOTIC EAR DROPS | 10000 UNIT | DROPS | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02458705 |
| BURO-SOL OTIC SOLUTION | 0.03 % | SOLUTION | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 00674222 |
| LIDOMYXIN | 10000 UNIT | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 00874949 |
| LIDOSPORIN EAR DROPS | 10000 UNIT | DROPS | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 00068454 |
| STAR-OTIC SOLUTION | 10 % | SOLUTION | STELLAR PHARMACAL CORP | CANCELLED POST MARKET | DIN 00852341 |
| VOSOL | 3 % | LIQUID | CARTER-HORNER CORP. | CANCELLED POST MARKET | DIN 00355046 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.